News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|May 23, 2016

About Michael's Accidental Diagnosis

Episodes in this series

EP. 1 About Michael's Accidental Diagnosis

EP. 1 About Michael's Accidental Diagnosis

EP. 2 Typical Presentation of Melanoma

EP. 2 Typical Presentation of Melanoma

EP. 3 Procedures Used to Diagnose Melanoma

EP. 3 Procedures Used to Diagnose Melanoma

EP. 4 Evaluating Melanoma for Signs of Spread of Disease

EP. 4 Evaluating Melanoma for Signs of Spread of Disease

EP. 5 Considerations Surrounding Use of Interferon

EP. 5 Considerations Surrounding Use of Interferon

EP. 6 Additional Treatment Options for Melanoma Treatment

EP. 6 Additional Treatment Options for Melanoma Treatment

EP. 7 Suggestions To Proactively Move Forward

EP. 7 Suggestions To Proactively Move Forward

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Michelle Anderson-Benjamin

Hospice May Offer Patients With Cancer Some Peace, Comfort and Control

December 18th 2025

breast cancer

New Approach May Offer Stronger Treatment Effects in Metastatic Breast Cancer

December 18th 2025

Dan, a pancreatic cancer survivor

Stage 4 Pancreatic Cancer Survivor Shares Clinical Trial Path

BySpencer Feldman

December 18th 2025

The U.S. FDA has granted approval to Rybrevant Faspro, the first and only subcutaneous therapy for EGFR-mutated non-small cell lung cancer: © stock.adobe.com.

Rybrevant Faspro FDA-Approved as First Sub-Q Therapy for EGFR NSCLC

December 18th 2025

Dave Coulier, best known for his role in the sitcom “Full House,” recently sat down with CURE to discuss facing cancer for the second time.

‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis

December 17th 2025

Trending on CURE

‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis

Rybrevant Faspro FDA-Approved as First Sub-Q Therapy for EGFR NSCLC

FDA Grants Regular Approval to Rubraca for Some With Prostate Cancer

Padcev/Keytruda Combo Extends Survival in Muscle-Invasive Bladder Cancer

GSK’227 Wins FDA Orphan Drug Designation in Small-Cell Lung Cancer